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Abstract 
Biomaterials interact with the host organism, determining the success or failure of an 
implantation. In vitro testing is used to assess the biocompatibility of a material. 
Unfortunately, in vitro and in vivo results are not always concordant. New methods for  
biomaterial characterisation are needed for an effective prediction of in vivo outcome. 
The first layer of proteins conditions the host response. Four distinct hybrid sol-gel 
biomaterials were tested. No differences in vitro were observed, although in vivo show 
distinct material behaviour. To characterise the first layer of proteins adsorbed onto the 
different surfaces, a mass spectrometry experiment was carried out. Six of the 171 
proteins adsorbed onto the surfaces were significantly more abundant on the materials 
with weak biocompatibility, with known relation to the complement pathway. This could 
indicate that protein analysis might be a suitable tool for the prediction of the in vivo 
outcome of implantations using new biomaterials. 
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Introduction 
 
Newly developed biomaterials used in the field of medical engineering and 
regenerative medicine require in vitro testing to assess their safety and efficacy. One of 
the major drawbacks of implantations is the induction of foreign body reaction, which 
might include an acute and chronic inflammation and scar tissue formation (Duffield et 
al. 2008; Boehler et al. 2011),  conditions that cannot be tested in vitro. Consequently, 
the in vitro outcome does not predict well the in vivo behaviour of a given biomaterial. It 
is, therefore, necessary to develop new methods for characterisation of biomaterials, 
with sufficient accuracy to predict the outcome of implantation (Hulsart-Billström et al. 
2016). 
Biomaterials interact with the host organism on several levels of biological organization, 
and this interface with the host organism might determine the success or failure of the 
implant. In particular, the surface properties of the implanted device (eg, hydrophilicity, 
roughness or surface energy) are important for defining a path of tissue remodelling 
(Molino et al. 2012). 
When a biomaterial interacts with the bodily fluids of the host, it triggers a natural 
immune response to the foreign body. The immune response starts with the activation 
of the innate immune system, a normal short-term reaction. However, sometimes, the 
implant might induce chronic inflammation and the formation of a fibrous capsule 
((myo)fibroblasts, neutrophils and foreign body giant cells (Damanik et al. 2014)), 
leading to implant rejection (Boehler et al. 2011). 
The understanding of the biological events after the implantation trauma is crucial in 
the development of new biomaterials to prevent or control blood coagulation, infections, 
immune response and, ultimately, implant rejection. It has been suggested that the 
differences between the foreign body reactions induced by different biomaterials are 
mostly determined by the first layer of serum proteins adsorbed onto the implant 
surface (Brash & Ten Hove 1984; Anderson et al. 2008). The adsorption mechanisms 
are not yet completely elucidated (Arvidsson et al. 2007); however, the first protein 
layer is likely to be responsible for the cell/organism response to the foreign bodies 
(Engberg et al. 2015). 
Proteomics has at its disposal powerful tools to examine the proteins adsorbed on 
different surfaces (Kaneko et al. 2011). In a previous study, we have reported 
differences between the compositions of protein layers deposited onto two distinct 
titanium surfaces (Romero-Gavilán et al. 2017). Some authors have proposed the 
C4/C4BP protein ratio as a predictor of biomaterial biocompatibility (Engberg et al. 
2015). Other studies indicate that binding of C3 protein onto biomaterials is correlated 
with their biocompatibility (Nilsson-Ekdahl et al. 1993). It is, therefore, tempting to 
assume a direct link between the proteins absorbed on the biomaterial surface and the 
elicited inflammatory response (Chen et al. 2015). However, the mechanisms of the 
immune response to biomaterials remain largely unknown (Vishwakarma et al. 2016). 
The hybrid sol-gel materials synthesised using alkoxysilanes have shown great 
potential in biomedical applications (P. Chiriac et al. 2011). These biomaterials, during 
their degradation process, release silicon compounds in the Si(OH)4 form (Juan-Díaz et 
al. 2016a), imparting the osteoinductive properties (Khan et al. 2014). 
Our research group has been working on sol-gel biomaterials applied as coatings on 
dental implants. A variety of compositions based on mixtures of different alkoxysilanes 
had been developed and widely studied (Hernández-Escolano et al. 2013; Juan-Díaz 
et al. 2014; Martínez-Ibáñez et al. 2016; Juan-Díaz et al. 2016b). In our previous 
studies, a poor correlation between in vitro and in vivo results has been observed for 
some of these biomaterials. Whereas only small differences between the two studied 
surfaces have been found in vitro, a completely diverse in vivo behaviour has been 
observed. The objective of the current study was to characterise the first protein layer 
absorbed on titanium discs coated with four distinct hybrid silica sol-gel formulations. 
Two of the formulations induced the formation of a fibrous connective tissue 
surrounding the implant (poor biocompatibility), whereas the other two showed good 
osteointegration (good biocompatibility). We examined the correlation between the 
properties of the first adsorbed protein layer with the in vivo outcome of implantation for 
the four tested coatings.  
 
 
 
 
 
 
 
 
  
 Materials and methods 
Titanium discs 
Titanium (Ti) discs (12 mm in diameter, 1-mm thick) were made from commercially 
available, pure, grade-4 Ti bar (Ilerimplant SL, Lleida, Spain). We used sandblasted 
acid-etched (SAE) Ti discs, abraded with 4-μm aluminium oxide particles and acid-
etched by submersion in sulphuric acid for 1 h to simulate a moderately rough implant 
surface. Discs were then washed in acetone, ethanol and 18.2 Ω puriﬁed water (for 20 
min in each liquid) in an ultrasonic bath and dried under vacuum. Finally, all Ti discs 
were sterilised using UV irradiation. 
Sol-gel synthesis and sample preparation 
The silica hybrid coatings were obtained using the sol-gel route. The alkoxysilanes 
precursors used were methyltrimethoxysilane (MTMOS), 3-glycidoxypropyl-
trimethoxysilane (GPTMS), tetraethyl orthosilicate (TEOS) and triethoxyvinylsilane 
(VTES) (Sigma-Aldrich, St. Louis, MO, USA). Four different compositions were 
synthesised with molar percentages of 70% MTMOS and 30% TEOS (70M30T), 35% 
MTMOS, 35% GPTMS and 30% TEOS (35M35G30T), 50% MTMOS and 50% GPTMS 
(50M50G) and 50% VTES and 50% GPTMS (50V50G). 2-Propanol (Sigma-Aldrich, St. 
Louis, MO, USA) was used as a solvent in the alcohol-siloxane mix (volume ratio 1:1). 
Hydrolysis of alkoxysilanes was carried out by adding (drop s-1) the corresponding 
stoichiometric amount of acidified aqueous solution 0.1M HNO3 (Panreac, Barcelona, 
Spain). The solution was stirred for 1 h and left to rest for 1 h; the samples were 
prepared immediately after this stage. SAE titanium discs were used as the substrate. 
The coating was performed employing a KSV DC dip-coater (Biolin Scientific, 
Stockholm, Sweden). The discs were introduced into the appropriate sol-gel solution at 
a speed of 60 cm min-1, for one minute, and removed at a 100 cm min-1. Finally, 
samples were cured for 2 h (0M30T and 35M35G30T coatings at 80 ºC, and 50M50G 
and 50V50G, at 140 ºC). 
 
Physicochemical characterisation of coated titanium discs 
The contact angle was measured using an automatic contact angle meter OCA 20 
(DataPhysics Instruments, Filderstadt, Germany). An aliquot of 10 µL of ultrapure water 
W04 was deposited on the sol-gel coated surface at a dosing rate of 27.5 μL s-1 at 
room temperature. Contact angles were determined using SCA 20 software 
(http://www.dataphysics.de/startseite/produkte/software-module/). Five discs of each 
material were examined (two drops deposited on each). The surface topography of 
coated titanium discs was characterised using atomic force microscopy (AFM) (Bruker 
Multimode 8, MA, USA) under dry conditions. Measurements were carried out at scan 
size of 60 µm, with a scan rate of 1 Hz. A mechanical profilometer Dektack 6M (Veeco, 
NY, USA) was used to determine the roughness. Two coated discs of each 
composition were tested. Three measurements were performed for each disc to obtain 
the average values of the Ra parameter. The coatings were studied using scanning 
electron Leica-Zeiss LEO microscope (SEM; Leica, Wetzlar, Germany) under vacuum. 
Platinum sputtering was applied to increase conductivity for the SEM. 
 
In vitro assays 
Cell culture 
MC3T3-E1 (mouse calvaria osteosarcoma cell line) cells were cultured on the sol-gel 
coated titanium discs at a concentration of 1 × 104 cells/well. We used the Dulbecco’s 
Modified Eagle's medium (DMEM) with phenol red (Thermo Fisher Scientific, Waltham, 
MA, USA), 1% 100× penicillin/streptomycin (Biowest Inc., Riverside, KS, USA) and 
10% fetal bovine serum (FBS) (Thermo Fisher Scientific, Waltham, MA, USA). The 
cells were incubated for 24 h at 37 ºC in a humidified (95%) atmosphere with 5% CO2. 
Then, the medium was replaced with an osteogenic medium composed of DMEM with 
phenol red 1×, 1% penicillin/streptomycin, 10% FBS, 1% ascorbic acid (5 mg mL-1) and 
0.21% β-glycerol phosphate, and the cells were incubated again under the same 
conditions. The culture medium was changed every 48 h. Wells without Ti discs were 
used as a control of culture conditions. 
Cytotoxicity 
The cytotoxicity of the biomaterials was assessed following the ISO 10993-5 norm.  
The 96-Cell Titter Proliferation Assay (Promega®, Madison, WI, USA) was employed to 
measure the cell viability after 24-h incubation of the cells with the extract. We used 
cells not exposed to the biomaterial extract as a negative control. At the same time, 
cells incubated with latex (known to be cytotoxic) were used as a positive control; 70% 
of cell viability was considered the limit below which a biomaterial was considered 
cytotoxic. 
  
Alkaline phosphatase (ALP) activity 
The conversion of p-nitrophenylphosphate (p-NPP) to p-nitrophenol was used to 
assess the ALP activity. Aliquots of 0.1 mL of cell lysate were used to conduct the 
assay. Lysate was obtained by adding 100 µL of lysate buffer (0.2% Triton X-100, 10 
mM  Tris-HCl pH 7.2) to each well. After a period of 7 min of ice, the samples were 
removed from the wells, transferred to microtubes, and sonicated for 2 min, obtaining 
the final lysate. Following centrifugation, 100 µL of p-NPP (1mg mL-1) in substrate 
buffer (50 mM glycine, 1 mM MgCl2, pH 10.5) was added to 100 µL of the supernatant 
obtained from the lysate. After a 2-h incubation in the dark (37 ºC, 5% CO2), the 
absorbance was spectrophotometrically measured using a microplate reader, at a 
wavelength of 405 nm. ALP activity was read from a standard curve, previously 
obtained using different solutions of p-nitrophenol and 0.02 mM sodium hydroxide. The 
results were presented as mmol p-nitrophenol per h (mM PNP h-1). The ALP activity 
data were normalised to the total protein content (µg µL-1) established using Pierce 
BCA assay kit (Thermo Fisher Scientific, Waltham, MA, USA), at 7 and 14 days. 
In vivo assay 
In vivo experimentation 
To evaluate the histological response to the selected coatings, dental implants were 
surgically placed in the tibia of New Zealand rabbits (Oryctolagus cuniculus). This 
implantation model is widely used for examining the osseointegration of dental implants 
(Mori et al. 1997). All experiments were conducted in accordance with the protocols of 
Ethical Committee at the University of Murcia (Spain), European guidelines, the legal 
conditions in R. D. 223/1988 of March 14th and the Order of October 13rd, 1988 of the 
Spanish Government law on the protection of experimental animals. The rabbits were 
kept under 12-h span darkness-light cyclic conditions; room temperature was set at 
20.5 ± 0.5 °C and the relative humidity ranged between 45 and 65%. The animals were 
individually caged and fed a standard diet and filtered water ad libitum. Dental implants 
were supplied by Ilerimplant SL (Lleida, Spain). The implants were of internal 
connection type, made with titanium grade-4 (trademark GMI dental implants, of 3.75-
mm diameter and 8-mm length, Frontier model). They had undergone the Advanced 
Doubled-Grip surface treatment, a combination of white corundum micro-bubble 
treatment and etching with nitric acid and sulphuric acid solution. We used 40 implants, 
20 uncoated (controls) and 5 coated (test samples) with each material. The control 
samples and test samples were implanted under the same conditions. 
We used 20 rabbits (5 for each material) with weights between 2000 and 3000 g. Their 
age was near the physical closure, which is indicative of an adequate bone volume. 
The implantation period was 2 weeks. This period was chosen to be able to examine a 
complete osseointegration process. The implants were inserted in the left and right 
proximal tibiae, two implants per animal (one control and one test sample). Animals 
were first sedated (chlorpromazine hydrochloride) and prepared for surgery, and then 
anesthetized (ketamine chlorhydrate). A coetaneous incision was made in the proximal 
tibia. The periosteum was removed, and the osteotomy was made using low revolution 
micromotor and drills of successive diameters of 2, 2.8 and 3.2 mm, with continuous 
irrigation. Implants were put in by press-fit, and the wound was sutured, washed with 
saline solution and covered with plastic spray dressing (Nobecutan, Inibsa 
Laboratories, Barcelona, Spain). At the end of each implantation period, the animals 
were euthanized by carbon monoxide inhalation to retrieve the screws and to study the 
surrounding tissues. 
 
Histological quantification 
Samples for histological examination were processed following the method described 
by Peris et al. (Peris et al. 1993). Briefly, the samples were embedded in methyl 
methacrylate, and 25–30 mm thick sections were obtained using EXAKT technique 
(EXAKT Technologies, Inc., Oklahoma, USA). For optical microscopy examination, all 
the sections were stained using Gomori Trichrome solution. The region of interest was 
delimited using the software ImageJ (https://imagej.nih.gov/ij/). The area occupied by 
connective tissue surrounding the implant was measured (mm2). 
 
Statistical analysis 
Data were submitted to one-way analysis of variance (ANOVA) and Newman-Keuls 
multiple comparison post-test, when appropriate. Differences with p ≤ 0.05 were 
considered statistically significant. 
 
Adsorbed protein layer 
Ti discs coated with different sol-gel compositions were incubated in 24-well plates for 
180 min in a humidified atmosphere (37 ºC, 5% CO2), after the addition of 2 mL of 
human blood serum from male AB plasma (Sigma-Aldrich, St. Louis, MO, USA). After 
the removal of the serum, the discs were rinsed five times with ddH2O and once with 
100 mM NaCl, 50 mM Tris-HCl, pH 7.0. The adsorbed protein layer was collected by 
washing the discs in a 4% SDS, 100 mM DTT, 0.5 M TEAB solution (Sigma-Aldrich, St. 
Louis, MO, USA) The experimental method was adopted from a study by Kaneko et al. 
(Kaneko et al. 2011). Four replicates of each biomaterial were used for analysis. Total 
protein content was quantified before the experiment (Pierce BCA assay kit; Thermo 
Fisher Scientific, Waltham, MA, USA), obtaining the value of 51 mg mL-1. 
Proteomic analysis 
The eluted protein sample was resolved on 10% polyacrylamide gels, using a Mini-
Protean II electrophoresis cell (Bio-Rad®, Hercules, CA, USA). A constant voltage of 
150 V was applied for 45 min. The gel was then stained using SYPRO Ruby stain (Bio-
Rad®, Hercules, CA, USA) following the manufacturer’s instructions. The gel was 
washed, and each lane was cut into 4 slices. Each of these slices was digested with 
trypsin following a standard protocol (Anitua et al. 2015). The resulting peptides were 
resuspended in 0.1% formic acid, separated using online NanoLC and analysed using 
electrospray tandem mass spectrometry. Peptide separation was performed on a 
nanoACQUITY UPLC system connected to a SYNAPT G2-Si spectrometer (Waters, 
Milford, MA, USA). Samples were loaded onto a Symmetry 300 C18 UPLC Trap 
column of 5 μm, 180 μm × 20 mm (Waters, Milford, MA, USA), connected to a BEH130 
C18 column of 1.7 μm, 75 μm × 200 mm (Waters, Milford, MA, USA). The column was 
equilibrated in 3% acetonitrile and 0.1% FA. Peptides were eluted at 300 nL min-1 using 
a 60-min linear gradient of 3−50% acetonitrile. 
 A SYNAPT G2-Si ESI Q-Mobility-TOF spectrometer (Waters, Milford, MA, USA) 
equipped with an ion mobility chamber (T-Wave-IMS) for high definition data 
acquisition analyses was used for the analysis of the peptides. All analyses were 
performed using electrospray ionization in a positive ion mode. Data were post-
acquisition lock-mass corrected using the double-charged monoisotopic ion of [Glu1]-
fibrinopeptide B. Accurate LC-MS data were collected in HDDA mode, which enhances 
signal intensities using the ion mobility separation. 
Progenesis LC-MS software (Nonlinear Dynamics) was used for differential protein 
expression analysis. Raw files were imported into the program, and one of the samples 
was selected for a reference run to which the precursor masses in all the other 
samples were aligned. Abundance ratio between the run to be aligned and the 
reference run were calculated for all features at given retention times. These values 
were then logarithmised and the programme, based on the analysis of the distribution 
of all ratios, automatically calculated a global scaling factor. Once normalised, the 
samples were grouped into the appropriate experimental categories and compared. A 
peak list containing the peptides detected in all samples was searched against a 
Swiss-Prot database using the Mascot search engine (www.matrixscience.com). 
Peptide mass tolerance of 10 ppm and 0.2-Da fragment mass tolerance were used for 
the searches. Carbamidomethylation of cysteines was selected as the fixed 
modification and oxidation of methionine as a variable modification for tryptic peptides. 
Proteins identified with at least two peptides with an FDR < 1% were kept for further 
examination. Proteins were quantified based on the intensity of their 3 most abundant 
peptides, when available. Proteins with ANOVA p < 0.05 and a ratio higher than 1.3 in 
either direction were considered significantly different. 
Finally, the data were entered in the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) Bioinformatics Resources to classify the Progenesis 
differential protein list into functionally related clusters. 
  
Results 
Synthesis and physicochemical characterisation 
Four different sol-gel compositions were coated onto the surface of SAE titanium discs. 
The coatings were homogeneous, without cracks, as can be seen on SEM micrographs 
(Figure 1).The 70M30T biomaterial conserved the initial titanium topography to a 
greater extent (Figure 1a) than 35M35G30T (b), 50M50G (c) and 50V50G (d). AFM 
images show that the 70M30T surface is the roughest (Figure 2a). The 35M35G30T 
(Figure 2b), 50M50G and 50V50G coatings display a smoother topography (Figure 2c 
and 3d), covering well the initially rough titanium surface. Mechanical profilometer 
measurements obtained a significantly higher Ra value for 70M30T than for 
35M35G30T, 50M50G and 50V50G coatings (Figure 3). This result may be due to the 
GPTMS in the last three biomaterials, which might affect the coating thickness, 
allowing an effective masking of the initial rough features. Contact angle 
measurements showed that the coatings with TEOS (non-organo-modified precursor), 
70M30T and 35M35G30T, were the most hydrophilic (Figure 4). The 50M50G and 
50V50G coatings had a larger contact angle, probably due to the higher organic matter 
content. 
In vitro assays 
None of the biomaterials was cytotoxic (Figure 5a). ALP activity measurements showed 
no significant differences between the tested materials (Figure 5b). Interestingly, 
whereas normalised ALP activity of control cells (wells without Ti disc) seemed to 
decrease with time, the cells grown on Ti and coated Ti discs maintained or even 
increased this activity. 
In vivo assays 
Histological analysis showed a good osseointegration pattern (it occurs on direct 
contact between the new bone and the implant surface) for 70M30T- and 35M35G30T-
coated implants (Figure 6b and 6c). However, using 50V50G (Figure 6d) and 50M50G 
(Figure 6e) coatings resulted in a formation of a distinct area of fibrous connective 
tissue between the material and the osteoid/newly formed bone. The sizes of these 
areas were similar for 35M35G30T and 70M30T but were larger in the 50V50G and 
50M50G samples (Figure 7). The materials were categorised into two groups according 
to the in vivo results. The first group, comprising 70M30T and 35M35G30T, achieved a 
good level of osseointegration (high biocompatibility). The coatings in the second 
group, composed of the 50M50G and 50V50G materials, caused the formation of 
fibrous connective tissue surrounding the implant surface, blocking the direct contact 
between the newly formed bone and the biomaterial (poor biocompatibility). 
Proteomic analysis 
The eluted proteins were analysed using LC-MS/MS. Progenesis QI software was 
employed to identify the proteins attached to different materials. The DAVID was used 
to classify according to their function. We detected and identified 171 proteins for each 
material. When comparing 70M30T with 35M35G30T (good biocompatibility group), 6 
proteins were identified as predominant on the 35M35G30T coating. The largest 
difference was observed for MYH1 protein (17.19-fold), involved in maintenance of 
cytoskeletal integrity. The other proteins were associated with the immune system 
(C1QA and FCN2) and metal-binding (HBA) functions. However, we found 3 proteins 
that adhered to the 70M30T coating in larger amounts than to 35M35G30T. These 
were the proteins involved in the protection against the inflammatory disorders (CLUS) 
(Cunin et al. 2016), coagulation (FAXII) (de Maat & Maas 2016) and lipid transport and 
carbohydrate binding (APOA5) (Table 1). 
It was also carried out a comparative study of proteins adhering to 50V50G and 
50M50G surfaces (poor biocompatibility group, Table 2). Two proteins were found 
adhering in substantially larger amounts to the 50V50G coating, both with metal-
binding functions (HORN and DSC1). The enzyme endopeptidase (LCN1) was found 
predominantly on 50M50G surfaces. The proteomic analysis showed few differences 
between the coatings in each group. On the two coatings with good biocompatibility, 
we found 9 differentially predominant proteins and only 3 on the poor biocompatible 
materials. 
To find an explanation for the differences in the in vivo outcomes, we compared the 
proteins differentially attached to each of the materials with good biocompatibility 
(70M30T and 35M35G30T) with the proteins detected on one of the materials with a 
negative outcome (poor biocompatibility group), 50M50G. Fifteen proteins were found 
predominantly adsorbed onto the 50M50G surface in comparison with the other two 
materials. They included the proteins involved in bone metabolism and regeneration 
(VTNC (Salasznyk et al. 2004), APOE (Shiraki et al. 1997; Newman et al. 2002; 
Rodrigues et al. 2012) and KNG1 (Tsuruga et al. 2006; Yamamura et al. 2006)) and 
proteins related to the immune system and inflammatory response (VTNC , CRP, 
SAMP, C1QB, C1QC, CO7, C1S and C4BPA). All these proteins seem to favour the 
complement cascade activation (Ricklin et al. 2010), except for C4BPA and VTNC 
(which might inhibit this process (Mollnes & Kirschfink 2006)). However, 5 proteins (3 
types of keratins, HORN and FILA2) adsorbed more to 70M30T and 35M35G30T than 
to 50M50G coatings. These proteins play a role in the cytoskeleton integrity and have a 
peptidase activity (Table 3). 
The proteins on the good biocompatibility materials (70M30T and 35M35G30T) were 
also compared with those found on the 50V50G coating (negative outcome). Table 4 
displays the 16 proteins with the highest abundance, among which 15 adhered more to 
the 50V50G coating. All the proteins characteristically associated with the 50V50G 
coating are directly involved in the immune response and acute inflammatory response 
(CRP, CO5, SAMP, C1QB, IC1, CFAH, CO7, C1S, CO3, C1R, VTNC and C1QC). 
Most of the proteins in this cluster are involved in the complement cascade activation 
(Ricklin et al. 2010), except for CFAH and VTNC, the important regulators/repressors 
of the activation of the complement system (Mollnes & Kirschfink 2006; Kishore & Sim 
2012). Only one protein, the endopeptidase SPB, was more abundant on both positive-
outcome materials than on 50V50G. 
To establish which proteins adhere differentially to both 50M50G and 50V50G (poor 
biocompatibility) in comparison with 35M35G30T and 70M30T (good biocompatibility) 
sol-gel coatings, the data in Tables 3 and 4 was analysed. The common proteins with 
increased abundance on the poor biocompatibility materials were looked for (Table 5). 
Nine such proteins were found, including VTCN, 2 immunoglobulins and 6 proteins 
related to the acute inflammatory response processes of the immune system (CRP, 
SAMP, C1QB, C1QC, C1S and CO7). 
These results demonstrate that the proteins related to the activation or inhibition of the 
complement cascade are adhered predominantly to 50M50G and 50V50G coatings. 
The complement system is a highly complex mechanism with the intricate regulation of 
inhibition and activation. Table 6 displays the abundance of adsorbed inhibitory 
proteins (C4BPS, CFAH and VTNC), comparing the materials with good and poor in 
vivo outcome and their respective protein ratios. The complement-inhibiting proteins 
C4BPA, CFAH and VTNC and two of the principal activating proteins of the same 
system, CRP and SAMP, were the main differentially adhering proteins on the poor-
outcome materials. Interestingly, the inhibitory proteins were more predominant in the 
weak biocompatibility material group. Nevertheless, the ratio of complement-system 
inhibitory proteins to activating proteins was higher for the biomaterials of good 
biocompatibility (70M30T and 35M35G30T) than for those with the poor 
biocompatibility (50M50G and 50V50G). 
  
Discussion 
Biomaterials and non-biological substances introduced into the human body are 
exposed to the blood and tissue elements. The first event after their introduction is the 
deposition of a monolayer of plasma proteins onto the surfaces of foreign materials. 
This can induce, among other processes, the activation of the complement system and 
coagulation cascades (Andersson et al. 2005). In extreme cases, it can result in a host 
reaction to the foreign body, which includes blood-material interactions, provisional 
matrix formation, acute and/or chronic inflammation, granulation tissue development 
and the formation of fibrous capsules (Luttikhuizen et al. 2006; Anderson et al. 2008). 
The physicochemical properties of the different biomaterials used in implants such as 
their topography, roughness, chemistry and surface energy might affect the types and 
quantities of adsorbed proteins and even their conformation (Vishwakarma et al. 2016) 
and, consequently, the body response. This paper focuses on the characterisation of 
the protein layer adsorbed onto titanium coated with four distinct silica hybrid sol-gel 
biomaterials (70M30T, 35M35G30T, 50M50G and 50V50G). The coatings had been 
originally introduced to make titanium implant surface more bioactive and increase its 
capacity of osteogenic molecule delivery (Martínez-Ibáñez et al. 2016; Juan-Díaz et al. 
2016b). The different compositions of the coatings change their physicochemical 
properties (Romero-Gavilán et al. 2016). Thus, 70M30T formulation resulted in the 
highest roughness in comparison with the others (all containing GPTMS). 50V50G and 
50M50G coatings were more hydrophobic than the other surfaces, probably due to 
their higher organic compound content. However, compositions containing TEOS (non-
organo-modified alkoxysilane) displayed a more hydrophilic behaviour. Apart from 
dissimilarities in morphology and hydrophilicity, these coatings also differ chemically, 
depending on the organo-modified alkoxysilanes used in their synthesis (Schottner 
2001). All these variations might affect the implant biocompatibility and, therefore, the 
biological response. 
None of the four biomaterials tested in vitro was found to be cytotoxic, and the ALP 
activity assay showed no significant differences. In fact, all the sol-gel compositions 
showed a good in vitro behaviour, even in comparison with the control sandblasted and 
acid-etched titanium (SAE-Ti), whose good properties are widely known (Wennerberg 
& Albrektsson 2009; Khorasani et al. 2015). 
Although in vitro experimentation is largely used to predict the host response to a 
biomaterial, it cannot accurately predict biocompatibility in vivo. This is because, in 
such experiments, many of the in vivo elements are missing (eg, the blood and the 
immune system). These elements strongly affect the in vivo result, especially in the 
field of osteoregenerative materials (Anderson 2016; Hulsart-Billström et al. 2016). 
During the bone regeneration process, the vascularisation, stabilisation, scaffolding, 
cell signalling and progenitor cells are all required (Giannoudis et al. 2007). Following 
the implantation, the material is in contact with the blood, which contains the innate 
immune system cells that might degrade the implanted material or induce the formation 
of connective tissue surrounding the implant, hampering the osteointegration. The 
formation of the fibrous capsule surrounding the implant is regarded a natural immune 
response of the host to a foreign body (Varley et al. 1995). 
A fibrous connective tissue was found surrounding 50M50G and 50V50G-coated 
implants; this did not happen in the cases 70M30T and 35M35G30T coatings even 
though they showed similar in vitro outcomes. Hence, even though in vitro tests might 
offer some guidance, neutral or positive results of such tests do not guarantee similar 
outcomes in vivo. 
The implanted biomaterials are exposed to the blood immediately after their insertion. 
The in vivo behaviour of a given biomaterial is difficult to predict; however, it has been 
proposed that the first layer of adhering serum proteins might be responsible for the 
different responses of the host organism (Ekdahl et al. 2013). 
Employing proteomic analysis using LC/MS-MS and the Progenesis software, the first 
layer of proteins was studied. Following examination of the proteins predominately 
adhered to the biomaterials with similar in vivo response (Tables 1 and 2), it was 
acknowledged that the differences within these groups of materials were very limited. 
However, when the two biomaterials with good biocompatibility were compared to 
either of the coatings inducing the formation of connective tissue, a significant number 
of differentially adhering proteins was detected. Interestingly, proteins related to the 
immune/inflammatory response were found predominantly on the poor biocompatibility 
surfaces 50M50G (Table 3) and 50V50G (Table 4), when compared simultaneously to 
70M30T and 35M35G30T (good biocompatibility). 
In parallel, it was also found (Table 5) some proteins differentially adhered to the two 
good biocompatibility materials (70M30T and 35M35G30T) in comparison with the poor 
biocompatibility coatings (50M50G and 50V50G). It is compelling that most of these 
proteins are associated with the immune system, including the pentraxins CRP and 
SAMP, as well as the complement proteins (C1QB, C1QC, C1S and CO7). The latter 
belong, according to the DAVID analysis, to a protein cluster related to an acute 
inflammatory response. Notably, CRP, an activator of the classical pathway (Du Clos 
2013) was particularly more abundant on the two materials with poor biocompatibility 
than on the 70M30T and 35M35G30T coatings. CRP acts by direct binding of the 
globular heads of C1q, the first component of the complement system (Ricklin et al. 
2010). We found that the amounts of C1q adhering to 50V50G and 50G50G surfaces 
were larger than on the coatings that achieve a good in vivo osseointegration. Upon the 
activation of C1q, the classical inflammatory pathway follows a series of complement 
activations, peaking on the generation of C3 and C5 convertases, which results in the 
production of C3a and C5b fragments. These are chemoattractant proteins with a role 
in the proliferation of the elements of the innate immunity system, such as 
macrophages (Ricklin et al. 2010). In turn, the macrophages regulate fibrogenesis by 
releasing the cytokines and growth factors. Furthermore, the macrophages modulate 
fibroblast proliferation and collagen synthesis (Song et al. 2000). However, the VTNC, 
which might participate in the regulation/repression of complement activation (Mollnes 
& Kirschfink 2006), is vital for interleukin IL-4 adhesion on biomaterial surfaces and 
induces the switch of the macrophages to their M2 reparative phenotype (Chen et al. 
2015). 
As this chain of events might lead to the formation of a fibrous capsule (a typical 
foreign body reaction of the host), it may seem paradoxical that the inhibitors of the 
complement system such as VTNC are found predominantly adhering onto 50M50G 
and 50V50G coatings, whose surfaces become surrounded by a layer of connective 
tissue after implantation. Explanation of this apparently contradictory finding might lie in 
the ratio of inhibitory to activator proteins on each surface. It is observed that the 
70M30T and 35M35G30T biomaterials showed a higher ratio of the complement 
system inhibitory proteins to activator proteins in comparison with the materials of poor 
biocompatibility. 
Our hypothesis is based on the fact that the equilibrium between the activating and 
inhibitory proteins regulating the complement system might determine the in vivo 
success of an implantation. Thus, a high ratio of inhibitory to activating proteins should 
lead to a positive outcome. A low ratio might trigger a disproportionate immune 
response with consequent excessive and chronic inflammation reaction, culminating in 
the formation of the fibrous capsule around the implant (Chen et al. 2015). This acute 
inflammation response might alter the normal balance between the coagulation 
cascade and the natural anticoagulant pathway, possibly by suppression of the latter 
(Opal & Esmon 2003). The anticoagulant pathway not only limits the coagulation but 
also modulates the inflammatory response (eg, by reduction of cytokine expression) 
(Esmon 2004). The lack of control in both coagulation and inflammatory pathways, a 
consequence of the anticoagulant system alteration, might cause a negative in vivo 
response after implantation. 
This hypothesis is consistent with other reports, in which the proteins of the 
complement system have been associated with biocompatibility problems (Mosqueira 
et al. 2001; Andersson et al. 2005). Engberg et al. have even proposed a method for 
prediction of biocompatibility by evaluating the ratio of C4/C4BP, assumed to reflect the 
inflammatory response of the host organism to a biomaterial (Engberg et al. 2015). 
However, in their study, a protein list was preselected; the CRP levels were not 
analysed in that publication. 
The proteomic approach using the LC/MS-MS might have a significant potential for 
predicting the biocompatibility of biomaterials by analysing the first layer of proteins 
attached to the tested surfaces. 
In summary, we tested four different hybrid sol-gel biomaterials with distinct physico-
chemical properties, which might affect the composition of the protein layer adhered to 
their surfaces. The implants with different coatings had different in vivo outcomes. Two 
of the implantations resulted in the formation of fibrous connective tissue between the 
implant and new bone (50V50G and 50M50G). The other two biomaterials achieved a 
successful osseointegration (70M30T and 35M35G30T). The results of our proteomic 
analysis suggested some reasons for these differences. In this paper is described a 
cluster of proteins differentially adhering to 50M50G and 50V50G coatings, which might 
negatively affect the osseointegration. Most of the proteins in this group have been 
associated with the acute inflammatory response. Therefore, the formation of the 
fibrous connective structure surrounding the 50M50G and 50V50G materials might be 
correlated with the adsorption of these proteins. The proteins in this group (CRP, 
SAMP, C1S, C1QB, C1QC, C7 and VTN) should be useful as biomarkers in the 
evaluations of material biocompatibility. 
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Tables and table captions 
Table 1. Proteins differentially predominant in 70M30T vs 35M35G30T sol-gel coating 
comparatives (Progenesis method). ANOVA (p-value < 0.05). DAVID classification 
functions were (1) inflammatory/immune response, (2) hydroxylation, (3) blood 
coagulation, (4) apoptosis regulation, (5) metal binding, (6) phosphorylation, (7) 
carbohydrate binding, (8) peptidase activity, (9) lipid transport and (10) cytoskeleton 
integrity.  
Description Accession Ratio 35M35G30T/70M30T DAVID 
Myosin-1 MYH1_HUMAN 17,19 10 
L-lactate dehydrogenase B chain LDHB_HUMAN 12,18 - 
Glutamate dehydrogenase 1, 
mitochondrial DHE3_HUMAN 8,65 - 
Ficolin-2 FCN2_HUMAN 8,28 1-2-7-5-10 
Complement C1q subcomponent 
subunit A C1QA_HUMAN 3,06 1-2 
Hemoglobin subunit alpha HBA_HUMAN 1,73 5-10 
Clusterin CLUS_HUMAN 0,61 1-4-9 
Coagulation factor XII FA12_HUMAN 0,58 3-5-8 
Apolipoprotein A-V APOA5_HUMAN 0,53 7-9 
 
Table 2. Proteins differentially predominant in 50M50G vs 50V50G sol-gel coating 
comparatives (Progenesis method). ANOVA (p-value < 0.05). DAVID classification 
functions were (1) inflammatory/immune response, (2) hydroxylation, (3) blood 
coagulation, (4) apoptosis regulation, (5) metal binding, (6) phosphorylation, (7) 
carbohydrate binding, (8) peptidase activity, (9) lipid transport and (10) cytoskeleton 
integrity.  
Description Accession Ratio 50V50G/50M50G DAVID 
Hornerin HORN_HUMAN 3,41 5-8-10 
Desmocollin-1 DSC1_HUMAN 2,14 5 
Lipocalin-1 LCN1_HUMAN 0,14 8 
 
  
Table 3. Proteins differentially predominant in both 70M30T vs 50M50G and 
35M35G30T vs 50M50G sol-gel coating comparatives (Progenesis method). ANOVA 
(p-value < 0.05). DAVID classification functions were (1) inflammatory/immune 
response, (2) hydroxylation, (3) blood coagulation, (4) apoptosis regulation, (5) metal 
binding, (6) phosphorylation, (7) carbohydrate binding, (8) peptidase activity, (9) lipid 
transport and (10) cytoskeleton integrity.  
Description Accession 
Ratio 
50M50G/ 
70M30T 
Ratio 
50M50G/ 
35M35G30T 
DAVID 
C-reactive protein CRP_HUMAN 7,83 5,28 1-5-8 
Lipocalin-1 LCN1_HUMAN 4,28 5,37 8 
Serum amyloid P-component SAMP_HUMAN 3,48 1,93 1-5-7-8 
Apolipoprotein E APOE_HUMAN 2,40 3,09 3-4-5-6-7-9 
Complement C1q subcomponent 
subunit C C1QC_HUMAN 2,26 2,12 1-2 
Complement C1q subcomponent 
subunit B C1QB_HUMAN 2,24 2,05 1-2 
Complement component C7 CO7_HUMAN 2,22 1,99 1 
Vitronectin VTNC_HUMAN 2,21 1,77 7 
Ig kappa chain V-IV region Len KV402_HUMAN 2,08 1,93 - 
Complement C1s subcomponent C1S_HUMAN 2,07 2,19 1-2-5-8 
C4b-binding protein alpha chain C4BPA_HUMAN 2,06 2,25 1 
Kininogen-1 KNG1_HUMAN 2,02 1,82 1-2-3-4-5-7 
Ig lambda-2 chain C regions LAC2_HUMAN 1,73 1,57 - 
Apolipoprotein A-IV APOA4_HUMAN 1,67 2,23 5 
Ig kappa chain V-II region Cum KV201_HUMAN 1,63 1,79 - 
Keratin, type II cytoskeletal 2 
epidermal K22E_HUMAN 0,63 0,62 10 
Keratin, type I cytoskeletal 10 K1C10_HUMAN 0,61 0,55 10 
Keratin, type II cytoskeletal 78 K2C78_HUMAN 0,60 0,56 10 
Hornerin HORN_HUMAN 0,40 0,16 5-8-10 
Filaggrin-2 FILA2_HUMAN 0,35 0,35 5-8 
 
  
Table 4. Proteins differentially predominant in both 70M30T vs 50V50G and 
35M35G30T vs 50V50G sol-gel coating comparatives (Progenesis method). ANOVA 
(p-value < 0.05). DAVID classification functions were (1) inflammatory/immune 
response, (2) hydroxylation, (3) blood coagulation, (4) apoptosis regulation, (5) metal 
binding, (6) phosphorylation, (7) carbohydrate binding, (8) peptidase activity, (9) lipid 
transport and (10) cytoskeleton integrity.  
Description Accession 
Ratio 
50V50G/ 
70M30T 
Ratio 
50V50G/ 
35M35G30T 
DAVID 
C-reactive protein  CRP_HUMAN 15,26 10,29 1-5-8 
Complement C5  CO5_HUMAN 10,43 5,78 1-6 
Serum amyloid P-component SAMP_HUMAN 3,33 1,84 1-5-7-8 
Complement C1q subcomponent 
subunit B C1QB_HUMAN 2,45 2,24 1-2 
Ig kappa chain V-IV region Len KV402_HUMAN 2,45 2,27 - 
Plasma protease C1 inhibitor IC1_HUMAN 2,22 1,66 1-3 
Complement factor H CFAH_HUMAN 2,09 1,73 1 
Complement component C7 CO7_HUMAN 2,07 1,86 1 
Ig kappa chain V-III region SIE KV302_HUMAN 2,03 1,83 - 
Complement C1s subcomponent C1S_HUMAN 1,98 2,10 1-2-5-8 
Vitronectin VTNC_HUMAN 1,98 1,58 7 
Complement C3 CO3_HUMAN 1,93 1,65 1 
Complement C1r subcomponent C1R_HUMAN 1,92 1,79 1-2-5-8 
Ig lambda-2 chain C regions LAC2_HUMAN 1,72 1,57 - 
Complement C1q subcomponent 
subunit C C1QC_HUMAN 1,71 1,61 1-2 
Serpin B3 SPB3_HUMAN 0,33 0,41 8 
 
Table 5. Proteins differentially predominant at the same time in both 50M50G and 
50V50G respect to 35M35G30T and 70M30T sol-gel coatings (Progenesis method). 
ANOVA (p-value < 0.05). 
Description Accession Ref. bone metabolism or/and immune response 
C-reactive protein CRP_HUMAN (Varley et al. 1995; Bottazzi et al. 2016; Ghafouri et al. 2016) 
Serum amyloid P-component SAMP_HUMAN (Sim et al. 1979; Fujimoto et al. 2015) 
Complement C1q subcomponent subunit C C1QC_HUMAN (Ricklin et al. 2010) 
Complement C1q subcomponent subunit B C1QB_HUMAN (Ricklin et al. 2010) 
Complement component C7 CO7_HUMAN (Ricklin et al. 2010) 
Vitronectin VTNC_HUMAN (Mao et al. 2014) 
Ig kappa chain V-IV region Len KV402_HUMAN - 
Complement C1s subcomponent C1S_HUMAN (Ricklin et al. 2010) 
Ig lambda-2 chain C regions LAC2_HUMAN - 
Table 6. Inhibitory/activator protein ratio detected in 70M30T, 35M35G30T, 50M50G 
and 50V50G biomaterials.  
Ratios 70M30T 35M35G30T 50M50G 50V50G 
CFAH/CRP 75,19 61,30 17,44 10,32 
CFAH/SAMP 2,04 1,37 1,07 1,28 
C4BPA/CRP 18,53 11,48 4,88 1,89 
C4BPA/SAMP 0,50 0,26 0,30 0,24 
VTNC/CRP 76,05 64,09 21,47 9,87 
VTNC/SAMP 2,06 1,43 1,31 1,23 
 
  
Figure captions 
Figure 1. SEM micrographs of hybrid sol-gel coatings on SAE titanium discs: 70M30T 
(a), 35M35G30T (b), 50M50G (c) and 50V50G (d). Calibration bar 10 µm. 
Figure 2. AFM images of hybrid sol-gel coatings: 70M30T (a), 35M35G30T (b), 
50M50G (c) and 50V50G (d).  
Figure 3. Mechanical profilometer measures of Ra. Bars indicate standard deviations. 
Figure 4. Contact angle results for sol-gel coatings on titanium discs. Bars indicate 
standard deviations. 
Figure 5. MC3T3-E1 cell viability and mineralization in vitro. Percentage of cell survival 
following the norm ISO 10993-5 (a) ALP activity (mM PNP h-1) normalized to the 
amount of total protein (µg µL-1) levels of the MC3T3-E1 cells cultivated on titanium 
discs treated with 70M30T (dotted column), 35M35G30T (checkered column), 50M50G 
(diagonal striped column) and 50V50G (horizontal striped column) formulations. Cells 
on an empty well without disc were used as a positive control (black column), whereas 
uncoated titanium discs (white column) were used as a negative control. There were no 
statistically significant differences between the different formulations at the times 
measured. 
Figure 6. Light microscopy representative images (EXAKT® cut and Gomori Trichrome 
stain) in vivo implants 2 weeks post-implantation of: a) representative photo of the area 
chosen to analyse the osseointegration state b) 70M30T, c) 35M35G30T, d) 50M50G 
and e) 50V50G sol-gel coated screws. The white arrows point to the area where the 
fibrous connective tissue was being formed. 
Figure 7. Area in mm2 occupied by the fibrous connective tissue ocuppied by the four 
tested coatings. Significantly differences between 70M30T/35M35G30T and 
50M50G/50V50G were found (ANOVA p≤0.05 with a Kruskal-Wallis post-test). 
 
